PetMed Express, Inc.(PETS) Intrinsic Value & DCF Analysis (2026)
Current Price
$1.81
Last updated: Jun 23, 2026
Price vs Intrinsic Value
Fundamental Score
Weighted across 6 signals
Narrative Score
No change vs previous
Trend Score
Trend data unavailable
The intrinsic value of PetMed Express, Inc. (PETS) is estimated at $-9.84 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $1.81, the stock appears overvalued relative to its projected cash flow fundamentals. This estimate assumes a -2.11% long-term growth rate and a 10.00% discount rate (calculated: 8.27%), reflecting expected future free cash flow and cost of capital.
The intrinsic value of PetMed Express, Inc. (PETS) is estimated at $-9.84 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $1.81, the stock appears overvalued relative to its projected cash flow fundamentals. This estimate assumes a -2.11% long-term growth rate and a 10.00% discount rate (calculated: 8.27%), reflecting expected future free cash flow and cost of capital.Valuation Details
Capital Efficiency
The company is earning below its required return. This may indicate inefficient use of capital or excess cash that isn't being reinvested.
Fundamental Details
Narrative Details
Trend Details
Investment Coach
- Price moves to at least a mid-teens discount to fair value
- Improvement in ROIC versus WACC spread
- Meaningful shifts in the narrative trend and score direction
Free Cash Flow (in millions)
How Intrinziq Estimates Fair Value
Intrinziq estimates PetMed Express, Inc.'s intrinsic value using a discounted cash flow (DCF) model based on free cash flow trends and a market-based discount rate. The model projects future cash flows over ten years and discounts them using a market return assumption to estimate fair value.
PetMed Express, Inc.Healthcare
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.